The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
This chapter contains sections titled:
Requirements for an Effective Hemovigilance Scheme
The Scope of Hemovigilance
Models of Hemovigilance in Different Countries
Development of Hemovigilance Worldwide
Hemovigilance Related to Blood Donors and Blood Donation
Learning from Hemovigilance
Disclaimer
References
Appendix 44‐1. ISBT Criteria for Severity and Imputability of Transfusion Reactions
Appendix...
This chapter contains sections titled:
Beneficial Clinical TRIM Effects
Deleterious Clinical TRIM Effects
TRIM Effects Mediated by Soluble Molecules Circulating in Allogeneic Plasma
TRIM Effects Mediated by WBC‐Derived Soluble Mediators
TRIM Effects Mediated by Allogeneic Mononuclear Cells
Summary and Conclusions
Disclaimer
References
This chapter contains sections titled:
Incidence of Transfusion‐Associated Hepatitis
Hepatitis B Virus
Hepatitis D
Hepatitis C Virus
Non‐A, Non‐B, Non‐C Hepatitis
Summary
Disclaimer
References
This chapter contains sections titled:
Transfusion‐Transmitted Bacterial Infection of Red Blood Cells
Transfusion‐Transmitted Bacterial Infection of Plasma, Cryoprecipitate, and Derivatives
Transfusion‐Transmitted Bacterial Infection of Platelets
Strategies to Reduce the Risk of Posttransfusion Sepsis
Transfusion‐Transmitted Syphilis
Transfusion‐Transmitted Lyme Disease
Conclusion
Disclaimer
References...
This chapter contains sections titled:
The Molecular Basis of Prion Diseases
The Nature, Concentration, and Distribution of Infectivity
Transmissibility of CJD by Blood and Tissues
The Prevalence and Distribution of Subclinical Disease
Approaches to Risk Management
Ethical, Legal, and Societal Considerations
Acknowledgments
Disclaimer
References
This chapter contains sections titled:
Febrile Nonhemolytic Transfusion Reactions
Allergic Reactions
Anaphylactic and Anaphylactoid Reactions
Complications of Massive and Rapid Transfusion
Circulatory Overload
Toxic Reactions Resulting from Blood Manufacture or Processing
Reactions in Special Transfusion Settings
Summary
Disclaimer
References
This chapter contains sections titled:
Pathophysiology of GVHD
Features of TA‐GVHD
Clinical Presentation and Diagnosis of TA‐GVHD
Treatment of GVHD
Prevention of TA‐GVHD
Summary
Disclaimer
References
This chapter contains sections titled:
Pathophysiology
Transfusional Iron Burden
Clinical Features
Measurement of Iron Burden
Management
Summary
Disclaimer
References
This chapter contains sections titled:
Clinical Features
Pathophysiology
Diagnosis and Differential Diagnosis
Management and Outcome
Incidence and Epidemiology
Prevention
Conclusion
Disclaimer
References
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.